WCG

Weaver Consulting Group Portfolio holdings

AUM $362M
1-Year Return 11.55%
This Quarter Return
+2.36%
1 Year Return
+11.55%
3 Year Return
+43.57%
5 Year Return
+67.2%
10 Year Return
AUM
$287M
AUM Growth
+$16.4M
Cap. Flow
+$11M
Cap. Flow %
3.83%
Top 10 Hldgs %
35.1%
Holding
209
New
10
Increased
56
Reduced
84
Closed
4

Sector Composition

1 Technology 6.78%
2 Healthcare 2.72%
3 Financials 1.99%
4 Communication Services 1.97%
5 Consumer Discretionary 1.7%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BCLI
201
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$79.3K 0.03%
15,624
+2,334
+18% +$11.9K
VERU icon
202
Veru
VERU
$48.3M
$31.5K 0.01%
3,749
+1,520
+68% +$12.8K
FBIO icon
203
Fortress Biotech
FBIO
$84.5M
$19.5K 0.01%
+11,403
New +$19.5K
BLRX
204
BioLineRX
BLRX
$15.1M
$9.64K ﹤0.01%
+423
New +$9.64K
GROM
205
DELISTED
Grom Social Enterprises Inc. Common Stock
GROM
$4.32K ﹤0.01%
10,751
BMY icon
206
Bristol-Myers Squibb
BMY
$95B
-4,632
Closed -$251K
CME icon
207
CME Group
CME
$96.4B
-1,012
Closed -$218K
CRM icon
208
Salesforce
CRM
$233B
-681
Closed -$205K
UBER icon
209
Uber
UBER
$192B
-4,417
Closed -$340K